ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | +50.0% | 950 | -4.8% | 0.00% | – |
| Q2 2019 | $12,000 | -14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +27.3% | 998 | -11.8% | 0.00% | – |
| Q4 2018 | $11,000 | -38.9% | 1,131 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | +12.5% | 1,131 | +13.3% | 0.00% | – |
| Q2 2018 | $16,000 | +14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | 0.0% | 998 | -10.6% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 1,116 | +28.9% | 0.00% | – |
| Q3 2017 | $11,000 | +10.0% | 866 | +0.5% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 862 | +37.9% | 0.00% | – |
| Q1 2017 | $13,000 | +44.4% | 625 | +44.7% | 0.00% | – |
| Q4 2016 | $9,000 | +28.6% | 432 | +137.4% | 0.00% | – |
| Q3 2016 | $7,000 | +250.0% | 182 | +71.7% | 0.00% | – |
| Q2 2016 | $2,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |